SG11202009179TA - Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereof - Google Patents
Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereofInfo
- Publication number
- SG11202009179TA SG11202009179TA SG11202009179TA SG11202009179TA SG11202009179TA SG 11202009179T A SG11202009179T A SG 11202009179TA SG 11202009179T A SG11202009179T A SG 11202009179TA SG 11202009179T A SG11202009179T A SG 11202009179TA SG 11202009179T A SG11202009179T A SG 11202009179TA
- Authority
- SG
- Singapore
- Prior art keywords
- heteroaryl
- pharmaceutical use
- compounds substituted
- pyrazole compounds
- pyrazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018072557 | 2018-04-04 | ||
| PCT/JP2019/014721 WO2019194207A1 (fr) | 2018-04-04 | 2019-04-03 | Composé de pyrazole substitué par hétéroaryle et son utilisation médicinale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009179TA true SG11202009179TA (en) | 2020-10-29 |
Family
ID=68100257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009179TA SG11202009179TA (en) | 2018-04-04 | 2019-04-03 | Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereof |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10988462B2 (fr) |
| EP (1) | EP3778593A4 (fr) |
| JP (3) | JP7130588B2 (fr) |
| KR (1) | KR20200139696A (fr) |
| CN (1) | CN111902408B (fr) |
| AR (1) | AR114465A1 (fr) |
| AU (1) | AU2019249560B2 (fr) |
| BR (1) | BR112020019939A2 (fr) |
| CA (1) | CA3089092A1 (fr) |
| CL (1) | CL2020002550A1 (fr) |
| CO (1) | CO2020012353A2 (fr) |
| IL (1) | IL277686A (fr) |
| MX (1) | MX2020010433A (fr) |
| PE (1) | PE20201068A1 (fr) |
| PH (1) | PH12020551624A1 (fr) |
| SG (1) | SG11202009179TA (fr) |
| TW (1) | TWI805727B (fr) |
| WO (1) | WO2019194207A1 (fr) |
| ZA (1) | ZA202006053B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI805699B (zh) | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| AR114465A1 (es) * | 2018-04-04 | 2020-09-09 | Japan Tobacco Inc | Compuestos de pirazol sustituidos con heteroarilo y su utilización farmacéutica |
| KR20220057562A (ko) * | 2019-09-04 | 2022-05-09 | 니뽄 다바코 산교 가부시키가이샤 | 만성 신장병의 치료 또는 예방 방법 |
| CN114585387A (zh) * | 2019-09-04 | 2022-06-03 | 日本烟草产业株式会社 | 利用联用药物的糖尿病的治疗或预防方法 |
| WO2021187548A1 (fr) | 2020-03-19 | 2021-09-23 | 日本たばこ産業株式会社 | Méthode de traitement ou de prévention des insuffisances cardiaques chroniques |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2665898B1 (fr) | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| JPH04247081A (ja) | 1991-02-01 | 1992-09-03 | Takeda Chem Ind Ltd | ５員複素環酸アミド類 |
| FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| EP1591443B1 (fr) | 2003-02-07 | 2010-08-25 | Daiichi Sankyo Company, Limited | Derive de pyrazole |
| AU2004200420A1 (en) | 2003-03-11 | 2004-09-30 | Astellas Pharma Inc. | Inhibitor of cyclooxygenase |
| JP2006182648A (ja) | 2003-04-08 | 2006-07-13 | Dai Ichi Seiyaku Co Ltd | ７員複素環誘導体 |
| US20050075375A1 (en) | 2003-05-14 | 2005-04-07 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis C virus |
| WO2004113359A1 (fr) * | 2003-06-20 | 2004-12-29 | Kissei Pharmaceutical Co., Ltd. | Derive de pyrazole, composition de medicaments contenant ledit derive et intermediaire de production associe |
| TW200526588A (en) | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
| TW200526641A (en) | 2003-12-26 | 2005-08-16 | Daiichi Seiyaku Co | Amidopyrazole derivatives |
| DE102004028241B4 (de) * | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
| CN1980665A (zh) | 2004-07-07 | 2007-06-13 | 默克公司 | 吡唑酰胺衍生物，包含这些化合物的组合物和使用方法 |
| KR20070089151A (ko) | 2004-11-16 | 2007-08-30 | 지더블유 파마 리미티드 | 카나비노이드의 새로운 용도 |
| KR20070084455A (ko) * | 2004-11-23 | 2007-08-24 | 워너-램버트 캄파니 엘엘씨 | 지질혈증 치료용 ｈｍｇ ｃｏ-ａ 환원효소 억제제로서의7-(2ｈ-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체 |
| JP2008007405A (ja) * | 2004-12-07 | 2008-01-17 | Takeda Chem Ind Ltd | カルボキサミド誘導体 |
| WO2006132436A1 (fr) | 2005-06-08 | 2006-12-14 | Japan Tobacco Inc. | Composé hétérocyclique |
| JP4137956B2 (ja) | 2005-06-08 | 2008-08-20 | 日本たばこ産業株式会社 | 複素環化合物 |
| WO2007034279A2 (fr) | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | Antagonistes de c3a et leurs compositions pharmaceutiques |
| TWI378922B (en) * | 2005-10-21 | 2012-12-11 | Mitsubishi Tanabe Pharma Corp | A pyrazole compound |
| EP1991528A2 (fr) | 2006-01-18 | 2008-11-19 | Siena Biotech S.p.A. | Modulateurs de la sous-unité alpha 7 du récepteur nicotinique de l'acétylcholine et leurs applications thérapeutiques |
| US20080027014A1 (en) | 2006-07-28 | 2008-01-31 | Tanabe Seiyaku Co., Ltd. | Novel SGLT inhibitors |
| ES2430821T3 (es) * | 2006-10-10 | 2013-11-21 | Amgen Inc. | Compuestos de N-arilpirazol para usar contra la diabetes |
| EP2121619A2 (fr) | 2006-11-24 | 2009-11-25 | AC Immune S.A. | Nouveaux composés destinés au traitement de maladies associés à des protéines amyloïdes ou de type amyloïde |
| ES2587014T3 (es) | 2006-11-24 | 2016-10-20 | Ac Immune S.A. | Derivados de N-(metil)-piridin-2-amina para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide |
| CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
| JP4994295B2 (ja) * | 2007-04-20 | 2012-08-08 | 田辺三菱製薬株式会社 | 医薬組成物 |
| WO2009091813A1 (fr) | 2008-01-14 | 2009-07-23 | Wyeth | Composés utiles en tant qu'agonistes des récepteurs nicotiniques alpha7 de l'acétylcholine |
| KR20110028661A (ko) | 2008-07-15 | 2011-03-21 | 노파르티스 아게 | Ｄｇａｔ１ 억제제로서의 헤테로아릴 유도체 |
| EP2560966B1 (fr) | 2010-03-30 | 2021-01-06 | Verseon International Corporation | Composés aromatiques multisubstitués utilisés comme inhibiteurs de la thrombine |
| WO2011161615A1 (fr) * | 2010-06-24 | 2011-12-29 | Ranbaxy Laboratories Limited | Inhibiteurs de la 5-lipoxygénase |
| AR087701A1 (es) | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 | |
| JP6507234B2 (ja) * | 2014-10-02 | 2019-04-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ブルトンチロシンキナーゼ（ｂｔｋ）によって介入される障害の処置における使用のためのピラゾールカルボキサミド化合物 |
| TWI805699B (zh) | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| AR114465A1 (es) * | 2018-04-04 | 2020-09-09 | Japan Tobacco Inc | Compuestos de pirazol sustituidos con heteroarilo y su utilización farmacéutica |
-
2019
- 2019-04-03 AR ARP190100867A patent/AR114465A1/es unknown
- 2019-04-03 WO PCT/JP2019/014721 patent/WO2019194207A1/fr active Application Filing
- 2019-04-03 JP JP2019070965A patent/JP7130588B2/ja active Active
- 2019-04-03 EP EP19781265.4A patent/EP3778593A4/fr active Pending
- 2019-04-03 US US16/374,460 patent/US10988462B2/en active Active
- 2019-04-03 AU AU2019249560A patent/AU2019249560B2/en active Active
- 2019-04-03 BR BR112020019939-7A patent/BR112020019939A2/pt unknown
- 2019-04-03 TW TW108111928A patent/TWI805727B/zh active
- 2019-04-03 KR KR1020207029108A patent/KR20200139696A/ko unknown
- 2019-04-03 CA CA3089092A patent/CA3089092A1/fr active Pending
- 2019-04-03 PE PE2020001510A patent/PE20201068A1/es unknown
- 2019-04-03 MX MX2020010433A patent/MX2020010433A/es unknown
- 2019-04-03 CN CN201980024203.5A patent/CN111902408B/zh active Active
- 2019-04-03 SG SG11202009179TA patent/SG11202009179TA/en unknown
-
2020
- 2020-09-30 CO CONC2020/0012353A patent/CO2020012353A2/es unknown
- 2020-09-30 ZA ZA2020/06053A patent/ZA202006053B/en unknown
- 2020-09-30 IL IL277686A patent/IL277686A/en unknown
- 2020-10-01 CL CL2020002550A patent/CL2020002550A1/es unknown
- 2020-10-02 PH PH12020551624A patent/PH12020551624A1/en unknown
-
2021
- 2021-03-25 US US17/213,096 patent/US20220048896A1/en not_active Abandoned
-
2022
- 2022-08-24 JP JP2022132912A patent/JP2022166280A/ja not_active Ceased
-
2023
- 2023-06-08 US US18/331,779 patent/US20240166632A1/en active Pending
-
2024
- 2024-01-19 JP JP2024006530A patent/JP2024050645A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2020132318A (ru) | 2022-04-29 |
| JP2022166280A (ja) | 2022-11-01 |
| EP3778593A1 (fr) | 2021-02-17 |
| TWI805727B (zh) | 2023-06-21 |
| TW201942114A (zh) | 2019-11-01 |
| US20220048896A1 (en) | 2022-02-17 |
| WO2019194207A1 (fr) | 2019-10-10 |
| KR20200139696A (ko) | 2020-12-14 |
| AR114465A1 (es) | 2020-09-09 |
| BR112020019939A2 (pt) | 2021-01-05 |
| US20190330193A1 (en) | 2019-10-31 |
| CA3089092A1 (fr) | 2019-10-10 |
| US20240166632A1 (en) | 2024-05-23 |
| CN111902408A (zh) | 2020-11-06 |
| CN111902408B (zh) | 2023-11-14 |
| JP7130588B2 (ja) | 2022-09-05 |
| PE20201068A1 (es) | 2020-10-19 |
| CO2020012353A2 (es) | 2021-01-18 |
| ZA202006053B (en) | 2022-03-30 |
| EP3778593A4 (fr) | 2021-12-22 |
| MX2020010433A (es) | 2020-10-28 |
| AU2019249560A1 (en) | 2020-07-23 |
| JP2019182852A (ja) | 2019-10-24 |
| AU2019249560B2 (en) | 2023-10-05 |
| PH12020551624A1 (en) | 2021-07-12 |
| JP2024050645A (ja) | 2024-04-10 |
| US10988462B2 (en) | 2021-04-27 |
| IL277686A (en) | 2020-11-30 |
| CL2020002550A1 (es) | 2021-01-15 |
| RU2020132318A3 (fr) | 2022-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202001340B (en) | Heterocyclic compound and use thereof | |
| EP3594202A4 (fr) | Composé de pyrrolidine substituée et son utilisation | |
| EP3594203A4 (fr) | Composé de pyrrolidine substituée et son utilisation | |
| IL277686A (en) | Heteroaryl-substituted pyrazole compounds and their pharmaceutical use | |
| IL290745A (en) | A pyrimidine compound and its pharmaceutical use | |
| ZA202007547B (en) | Heteroaryl compounds and uses thereof | |
| IL273339A (en) | Griseofulbin compound and its medical use | |
| EP3344613A4 (fr) | Composés hétéroaryle et leur utilisation comme médicaments thérapeutiques | |
| IL273573A (en) | Nitrogen-containing heteroaryl compound and medicinal use thereof | |
| IL267626B1 (en) | Teraaryl compounds and their uses | |
| IL276290A (en) | Heteroaryl compounds, their pharmaceutical preparations and their medical use | |
| IL276323A (en) | 4-Methyldihydropyrimidinone compounds and their pharmaceutical use | |
| EP3681877A4 (fr) | Composé dérivé de pyrazole et son utilisation | |
| IL276912A (en) | Heterocyclic compound and its use | |
| SG11202007119UA (en) | Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof | |
| EP3851108C0 (fr) | Médicament à base de borate et utilisation associée | |
| EP3696178A4 (fr) | Composé hétérocyclique et son application en médecine | |
| EP3568137A4 (fr) | Composés hétérocycliques et utilisation de ces composés | |
| IL276410A (en) | Pyrazole compounds and their preparation | |
| ZA202000959B (en) | Adamantylmethylamine derivative and use thereof as pharmaceutical | |
| EP3845528A4 (fr) | Composés de pyrazole, compositions pharmaceutiques correspondantes et utilisation associées | |
| EP3718543A4 (fr) | Composition pharmaceutique et son utilisation | |
| IL283315A (en) | Heterocyclic compounds and medical use thereof |